Celltrion
068270.KS
#724
Rank
$27.31 B
Marketcap
$133.30
Share price
0.05%
Change (1 day)
-7.89%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of September 2024 : $15.50 Billion USD

According to Celltrion 's latest financial reports the company's total assets are $15.50 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31$4.67 B-2.01%
2021-12-31$4.76 B3.2%
2020-12-31$4.62 B38.44%
2019-12-31$3.33 B6.36%
2018-12-31$3.13 B1.56%
2017-12-31$3.08 B29.16%
2016-12-31$2.39 B6.47%
2015-12-31$2.24 B5.97%
2014-12-31$2.12 B12.99%
2013-12-31$1.87 B12.42%
2012-12-31$1.66 B37.52%
2011-12-31$1.21 B18.4%
2010-12-31$1.02 B111.03%
2009-12-31$0.48 B20.87%
2008-12-31$0.40 B505.79%
2007-12-31$66.34 M